• No results found

Additional Table 1

N/A
N/A
Protected

Academic year: 2021

Share "Additional Table 1"

Copied!
1
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Additional Table 1

m e a n SD m e a n SD m e a n SD m e a n SD m e a n SD m e a n SD m e a n SD m e a n SD m e a n SD m e a n SD m e a n SD 1

He

nei

co

sa

ne

C 21 1 7 .1 8 0. 08 0. 04 0. 16 0. 44 3. 29 0. 89 0 .0 2 0 .0 1 0 .0 3 0 .0 1 0 .0 1 0 .0 0 0 .0 2 0 .0 2 0 .2 8 0 .0 5 0 .1 5 0 .0 8 0 .2 5 0 .0 3 0 .0 7 0 .0 1 2

D

oc

osa

ne

C 22 1 9 .7 9 0. 06 0. 09 0. 33 0. 47 0. 61 0. 20 0 .0 5 0 .0 1 0 .0 5 0 .0 2 0 .0 3 0 .0 1 0 .0 2 0 .0 0 0 .1 2 0 .0 4 0 .1 0 0 .0 3 0 .0 8 0 .0 5 0 .1 1 0 .0 6 3

9-T

ri

co

sa

ne

C 23: 1 2 1 .7 4 0. 04 0. 03 0. 24 0. 55 2. 33 0. 87 0 .0 2 0 .0 1 0 .0 9 0 .1 3 0 .1 4 0 .0 5 0 .1 6 0 .2 4 0 .8 7 0 .1 2 0 .2 2 0 .1 6 0 .3 1 0 .0 7 0 .1 0 0 .0 4 4

T

ri

co

sa

ne

C 23 2 2 .5 2 0. 32 0. 17 1. 88 2. 13 17. 73 5. 54 0 .3 6 0 .1 8 0 .5 1 0 .3 5 0 .4 8 0 .1 0 0 .4 8 0 .3 1 3 .2 3 0 .5 2 2 .3 4 1 .0 6 2 .2 4 0 .2 6 0 .6 1 0 .1 1 5

T

etr

ac

osa

ne

C 24 2 5 .0 8 0. 19 0. 22 0. 72 1. 09 0. 63 0. 28 0 .2 7 0 .1 1 0 .2 5 0 .1 2 0 .2 5 0 .0 2 0 .1 5 0 .0 3 0 .2 7 0 .0 5 0 .3 4 0 .0 8 0 .2 7 0 .0 5 0 .1 8 0 .0 6 6

9-Pen

tac

osa

ne

C 25: 1 2 7 .1 0 16. 92 5. 70 5. 95 5. 22 30. 57 7. 57 2 .1 9 0 .6 5 3 .3 7 3 .0 1 1 1 .3 6 2 .4 0 4 .8 5 3 .9 2 2 4 .8 4 1 .4 9 7 .9 9 3 .2 4 2 4 .1 1 1 .3 1 3 .3 4 0 .7 9 7

11

-Pen

tac

osa

ne

C 25: 2 2 7 .2 0 0. 22 0. 11 0. 28 0. 14 0. 73 0. 20 0 .2 4 0 .1 0 0 .2 5 0 .0 8 0 .3 8 0 .0 8 0 .3 4 0 .1 2 0 .5 3 0 .0 5 0 .3 0 0 .0 8 0 .4 9 0 .0 7 0 .2 8 0 .1 0 8

Pen

tac

osa

ne

C 25 2 7 .8 7 13. 11 3. 40 14. 23 6. 05 12. 23 3. 10 1 1 .1 9 3 .1 4 1 0 .3 5 3 .0 5 1 7 .2 4 1 .5 8 9 .8 3 1 .3 3 1 2 .6 8 2 .0 4 1 6 .2 8 2 .5 2 1 1 .0 7 2 .1 7 9 .0 6 0 .8 6 9

He

xac

osa

ne

C 26 3 0 .1 0 0. 35 0. 26 1. 19 0. 76 0. 41 0. 33 0 .9 2 0 .3 3 0 .8 7 0 .4 1 0 .6 0 0 .1 0 0 .5 6 0 .1 0 0 .2 2 0 .0 5 0 .7 3 0 .0 8 0 .2 5 0 .0 5 0 .6 5 0 .1 3 10

5-He

pt

ac

osa

ne

C 27: 1 3 1 .9 6 2. 87 1. 04 4. 35 1. 54 4. 76 1. 11 4 .8 0 1 .4 1 4 .8 1 1 .5 3 7 .5 1 1 .7 3 6 .7 5 1 .9 8 5 .8 6 0 .5 8 4 .2 4 0 .5 4 4 .2 1 0 .4 3 3 .6 4 0 .8 5 11

He

pt

ac

osa

ne

C 27 3 2 .5 8 4. 21 0. 46 7. 19 1. 76 1. 25 0. 59 6 .8 7 1 .2 7 6 .9 9 1 .3 4 7 .5 5 1 .4 1 8 .1 9 2 .5 9 2 .7 7 0 .4 3 5 .9 2 0 .7 9 3 .6 1 0 .3 2 7 .8 5 0 .7 3 12

O

ct

ac

osa

ne

C 28 3 4 .8 0 0. 33 0. 36 1. 12 0. 89 0. 43 0. 63 0 .9 6 0 .4 4 0 .8 1 0 .5 3 0 .3 0 0 .0 6 0 .4 0 0 .1 0 0 .1 6 0 .0 3 0 .4 0 0 .0 8 0 .1 8 0 .0 6 0 .4 7 0 .0 8 13

7-N

on

ac

osa

ne

C 29: 1 3 6 .5 7 3. 20 1. 08 2. 85 0. 94 2. 72 0. 62 4 .0 3 0 .8 1 3 .5 2 1 .4 2 4 .4 5 0 .9 1 3 .8 8 0 .9 9 5 .3 9 0 .7 8 3 .5 4 0 .6 4 4 .0 6 0 .4 6 2 .4 6 0 .6 8 14

N

on

ac

osa

ne

C 29 3 7 .1 7 9. 20 1. 43 7. 95 1. 68 1. 66 0. 88 8 .0 5 1 .5 3 7 .0 6 0 .9 8 8 .7 3 1 .8 9 8 .5 5 2 .7 1 4 .8 5 0 .5 9 7 .2 6 0 .7 7 6 .8 5 0 .6 1 7 .8 7 0 .6 0 15

9

-T

ri

ac

on

tan

e

C 30: 1 3 8 .7 3 0. 33 0. 09 0. 66 0. 23 0. 46 0. 11 0 .9 4 0 .2 5 1 .0 7 0 .5 9 0 .8 3 0 .2 3 1 .0 6 0 .5 2 0 .9 1 0 .1 0 0 .7 9 0 .1 2 0 .6 5 0 .0 9 0 .5 8 0 .1 2 16

T

ri

ac

on

tan

e

C 30 3 9 .2 3 0. 86 0. 34 2. 08 0. 86 0. 49 0. 62 2 .3 3 0 .4 8 2 .2 0 0 .5 0 1 .1 0 0 .2 4 1 .9 9 0 .4 5 0 .4 7 0 .0 9 1 .2 8 0 .2 3 0 .5 8 0 .0 7 1 .9 0 0 .1 9 17

9-He

nt

ri

ac

on

tan

e

C 31: 1 4 1 .0 8 23. 97 2. 76 16. 55 3. 54 14. 14 3. 50 2 0 .5 4 3 .1 0 1 8 .9 0 3 .9 4 1 5 .6 8 3 .0 6 1 6 .3 2 3 .8 0 2 3 .6 6 2 .7 4 1 7 .7 6 1 .6 9 2 3 .4 6 1 .8 5 1 6 .8 4 2 .0 3 18

He

nt

ri

ac

on

tan

e

C 31 4 1 .5 4 20. 71 6. 05 19. 03 5. 92 2. 24 1. 00 1 9 .6 9 3 .2 7 2 1 .2 0 6 .6 0 1 5 .9 5 3 .5 6 2 2 .1 2 6 .4 8 8 .5 5 1 .2 7 1 6 .4 5 2 .5 6 1 3 .8 5 1 .3 9 2 5 .3 7 2 .2 7 19

9-D

oc

ot

ri

ac

on

tan

e

C 32: 1 4 2 .9 5 0. 17 0. 05 0. 54 0. 21 0. 25 0. 08 0 .9 6 0 .2 3 0 .9 5 0 .1 9 0 .4 8 0 .1 4 0 .7 3 0 .2 7 0 .4 8 0 .0 4 0 .6 5 0 .1 3 0 .3 7 0 .0 6 0 .7 6 0 .1 0 20

D

oc

ot

ri

ac

on

tan

e

C 32 4 3 .3 8 0. 51 0. 23 1. 68 0. 76 0. 30 0. 29 1 .7 7 0 .4 3 1 .9 5 0 .7 2 0 .7 1 0 .1 6 1 .6 5 0 .4 3 0 .2 6 0 .0 7 1 .1 5 0 .2 5 0 .3 3 0 .0 9 1 .9 9 0 .2 4 21

9-T

ri

tr

iac

on

tan

e

C 33: 1 4 5 .1 8 0. 76 0. 27 5. 13 1. 85 2. 23 0. 82 8 .0 3 1 .6 6 7 .5 5 0 .5 8 3 .3 9 0 .7 9 5 .5 8 1 .0 9 2 .5 0 0 .2 0 6 .3 4 1 .0 5 1 .5 2 0 .2 4 6 .6 9 0 .9 4 22

T

ri

tr

iac

on

tan

e

C 33 4 5 .6 7 1. 60 0. 50 5. 91 2. 18 0. 55 0. 27 5 .7 7 1 .3 1 7 .2 3 2 .6 8 2 .8 3 0 .7 4 6 .3 8 1 .6 4 1 .0 9 0 .3 6 5 .7 7 1 .1 5 1 .2 6 0 .2 2 9 .1 7 1 .1 5

N=

1

6

N=

1

9

N=

1

2

N=

1

8

N=

9

N=

5

N=

4

N=

7

Q L C o lo n y 6 Q L & Q R C o lo n y 7 C o lo n y 8 W o rk er -tu rn -Ben d er s (D 1 ) W o rk er s-sta y-W o rk er s (D 1 ) W o rk er -tu rn -Ben d er s (D 7 ) W o rk er s-sta y-W o rk er s (D 7 ) Ben d er s [Q L 4 -9 d se] W o rk er [Q R 4 -9 d se] N ew Q u ee n s Q R W o rk er s

N=

2

4

N=

9

5

P e ak h yd ro ca rb o n / co m p o n e n t H C a b re v. R e t. Ti m e

N=

6

7

Q R A ll C o lo n ie s A ll C o lo n ie s Q u ee n s W o rk er s > 4 d se C a llo w s (0 d se)

Referenties

GERELATEERDE DOCUMENTEN

Pragmatic ‘The experimental intervention typically is applied by the full range of practitioners and in. the full range of clinical settings,

8 TABLE 8: LINEAR REGRESSION RESULTS FOR THE VARIABLES OF THE FORMAL INSTITUTIONS PERSPECTIVE USING FDI/GDP AS DEPENDENT VARIABLE.

Specifically, the study examined whether perceived Twitter brand account features (information quality, entertainment, vividness and interactivity) predicted the

Additional file 1: The table presents 16 elasmobranch species of southern Africa selected for cross-species amplification, including family, species/vernacular, distribution

understand the universe a little bit better, aiding in the creation of the Standard model and in understanding the world of space-time. A seemingly useless particle because of

Title/abstract search 2: Focus on review papers (Medline, CINAHL, and Embase) as well as title/abstract search of citations in review article #124). Title/abstract search of

IBP, inflammatory back pain; NSAIDs, Non-Steroidal Anti-Inflammatory Drugs; IBD, inflammatory bowel disease; HLA-B27, Human Leucocyte Antigen B27; ESR, erythrocyte sedimentation

Marie-Charlotte Ibanez, Judith Berendsen Ex 5.1.8 generator Ornstein-Uhlenbeck May 20 Matteo Quattropani, Giulia Pederzani Lemma 5.2.10 plus analogy with 4.4.5. Jian-He, Xavier